234 related articles for article (PubMed ID: 11786515)
1. Molecular pathogenesis of the antiphospholipid syndrome.
Rand JH
Circ Res; 2002 Jan; 90(1):29-37. PubMed ID: 11786515
[TBL] [Abstract][Full Text] [Related]
2. Anti-beta2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome.
Hanly JG; Smith SA
Clin Exp Immunol; 2000 Jun; 120(3):537-43. PubMed ID: 10844535
[TBL] [Abstract][Full Text] [Related]
3. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic role of antiprotein-phospholipid antibodies.
Carreras LO; Forastiero RR
Haemostasis; 1996 Oct; 26 Suppl 4():340-57. PubMed ID: 8979139
[TBL] [Abstract][Full Text] [Related]
5. The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis.
Rand JH; Wu XX; Quinn AS; Taatjes DJ
Lupus; 2010 Apr; 19(4):460-9. PubMed ID: 20353989
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid syndrome.
Arnout J; Jankowski M
Hematol J; 2004; 5 Suppl 3():S1-5. PubMed ID: 15190268
[No Abstract] [Full Text] [Related]
8. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.
Yasuda S; Bohgaki M; Atsumi T; Koike T
Immunobiology; 2005; 210(10):775-80. PubMed ID: 16325497
[TBL] [Abstract][Full Text] [Related]
9. [New targets of antiphospholipid antibodies].
Arvieux J; Darnige L; Sarrot-Reynauld F
Rev Med Interne; 1997; 18(4):292-302. PubMed ID: 9161556
[TBL] [Abstract][Full Text] [Related]
10. [Association between anti-phospholipid antibodies and thrombotic complications in systemic lupus erythematosus].
Nojima J
Rinsho Byori; 2003 Mar; 51(3):239-47. PubMed ID: 12707997
[TBL] [Abstract][Full Text] [Related]
11. Competition of annexin V and anticardiolipin antibodies for binding to phosphatidylserine containing membranes.
Willems GM; Janssen MP; Comfurius P; Galli M; Zwaal RF; Bevers EM
Biochemistry; 2000 Feb; 39(8):1982-9. PubMed ID: 10684648
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism.
de Laat B; Mertens K; de Groot PG
Nat Clin Pract Rheumatol; 2008 Apr; 4(4):192-9. PubMed ID: 18285765
[TBL] [Abstract][Full Text] [Related]
13. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
Bertolaccini ML; Hughes GR; Khamashta MA
Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
[TBL] [Abstract][Full Text] [Related]
14. Update on antiphospholipid antibodies.
Roubey RA
Curr Opin Rheumatol; 2000 Sep; 12(5):374-8. PubMed ID: 10990172
[TBL] [Abstract][Full Text] [Related]
15. Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid Interaction.
Gharavi AE; Cucurull E; Tang H; Silver RM; Branch DW
Am J Reprod Immunol; 1998 May; 39(5):310-5. PubMed ID: 9602248
[TBL] [Abstract][Full Text] [Related]
16. Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndrome.
Bećarević M; Sarić M; Stojanovich L; Mirković D; Dopsaj V; Ignjatović S
Clin Rheumatol; 2018 Dec; 37(12):3359-3364. PubMed ID: 29948348
[TBL] [Abstract][Full Text] [Related]
17. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
[TBL] [Abstract][Full Text] [Related]
18. Binding of anticardiolipin antibodies to protein C via beta2-glycoprotein I (beta2-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system.
Atsumi T; Khamashta MA; Amengual O; Donohoe S; Mackie I; Ichikawa K; Koike T; Hughes GR
Clin Exp Immunol; 1998 May; 112(2):325-33. PubMed ID: 9649198
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo.
Pierangeli SS; Colden-Stanfield M; Liu X; Barker JH; Anderson GL; Harris EN
Circulation; 1999 Apr; 99(15):1997-2002. PubMed ID: 10209004
[TBL] [Abstract][Full Text] [Related]
20. Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin.
Sheng Y; Hanly JG; Reddel SW; Kouts S; Guerin J; Koike T; Ichikawa K; Sturgess A; Krilis SA
Clin Exp Immunol; 2001 Jun; 124(3):502-8. PubMed ID: 11472415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
